1.91

2.14% 0.04

After Hours: 1.92 0.01 +0.52%

Gain Therapeutics Inc (GANX)

Overview News Price History Option Chain Financials Why GANX Down? Discussions Forecast

Gain Therapeutics Inc stock is traded at $1.91, with a volume of 434.04K. It is up +2.14% in the last 24 hours and up +2.69% over the past month. Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Previous Close:

$1.87

Open:

$1.89

24h Volume:

434.04K

Relative Volume:

0.65

Market Cap:

$81.47M

Revenue:

$55,200

Net Income/Loss:

$-20.16M

P/E Ratio:

-3.1128

EPS:

-0.6136

Net Cash Flow:

$-18.47M

1W Performance:

+8.52%

1M Performance:

+2.69%

6M Performance:

+0.53%

1Y Performance:

+1.06%

1-Day Range:

$1.8613

$1.93

1-Week Range:

$1.78

$1.95

52-Week Range:

$1.41

$4.34

Gain Therapeutics Inc Stock (GANX) Company Profile

Name

Gain Therapeutics Inc

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

(301) 500-1556

Address

4800 HAMPDEN LANE, BETHESDA

Employee

Twitter

Next Earnings Date

2026-05-13

Latest SEC Filings

GANX's Discussions on Twitter

Compare GANX vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GANX Gain Therapeutics Inc	1.91	79.76M	55,200	-20.16M	-18.47M	-0.6136
VRTX Vertex Pharmaceuticals Inc	427.65	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	721.05	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	807.55	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	303.00	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	313.32	33.06B	5.36B	287.73M	924.18M	2.5229

Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-07-25	Initiated	Scotiabank	Sector Outperform
Dec-06-24	Initiated	ROTH MKM	Buy
Aug-14-24	Resumed	Oppenheimer	Outperform
Apr-12-21	Initiated	BTIG Research	Buy
Apr-12-21	Initiated	Oppenheimer	Outperform

Gain Therapeutics Inc Stock (GANX) Latest News

May 04, 2026

GANX Technical Analysis | Trend, Signals & Chart Patterns | GAIN THERAPEUTICS INC (NASDAQ:GANX) - ChartMill

Apr 28, 2026

Apr 27, 2026

Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026 - marketscreener.com

Apr 27, 2026

Apr 24, 2026

Gain Flat Ahead of Arizona Conference - Baystreet.ca

Apr 24, 2026

Gain Therapeutics, Inc. to Present Update on Parkinson’s Disease Drug GT-02287 at 3rd International GBA1 Meeting 2026 - Quiver Quantitative

Apr 24, 2026

Gain to present Parkinson’s drug update at Phoenix GBA1 meeting - Stock Titan

Apr 24, 2026

Apr 23, 2026

GANX Gain Therapeutics posts narrower Q4 2025 loss than estimates, but shares fall 2.39%.EPS Growth - Newser

Apr 23, 2026

Apr 17, 2026

GANX | Gain Therapeutics, Inc. Common Insider Trading - Quiver Quantitative

Apr 17, 2026

Apr 13, 2026

Breakout Watch: Does Gain Therapeutics Inc have a sustainable dividendMarket Risk Analysis & Fast Exit and Entry Trade Guides - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Gain Therapeutics, Inc. (NASDAQ:GANX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Apr 12, 2026

Apr 11, 2026

GANX Should I Buy - Intellectia AI

Apr 11, 2026

Apr 09, 2026

Technical Analysis: Will Gain Therapeutics Inc benefit from green energy policiesQuarterly Trade Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Weekly Recap: Is Gain Therapeutics Inc a strong candidate for buy and holdMarket Sentiment Report & Real-Time Market Trend Scan - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Death Cross: Is Gain Therapeutics Inc attractive for institutional investorsPortfolio Value Report & Real-Time Stock Entry Alerts - baoquankhu1.vn

Apr 07, 2026

Stop Loss: What hedge funds are buying Gain Therapeutics IncInsider Selling & Long-Term Growth Stock Strategies - baoquankhu1.vn

Apr 07, 2026

Quarterly Trades: What hedge funds are buying Gain Therapeutics Inc2026 Spike Watch & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026